Examples of using Multiple doses in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Each pen contains multiple doses.
Single and multiple doses of 8 mg and 12 mg impaired psychomotor performance in healthy volunteers in a dose-related manner.
Ingle dose/cobicistat 150 mg multiple doses.
Multiple doses of ambrisentan had no effect on cyclosporine A exposure, and no dose adjustment of cyclosporine A is warranted.
Single dose versus multiple doses.
There is little or no accumulation of topotecan with repeated daily dosing andthere is no evidence of a change in the PK after multiple doses.
Accumulation of parent drug or monomethyl fumarate does not occur with multiple doses of dimethyl fumarate at the therapeutic regimen.
There is little or no accumulation of topotecan with repeated daily dosing andthere is no evidence of a change in the PK after multiple doses.
There was a small benefit in the relief of nasal congestion from multiple doses, but it was unclear if this was beneficial for patients.
Co-administration of multiple doses of empagliflozin and metformin does not meaningfully alter the pharmacokinetics of either empagliflozin or metformin in healthy subjects.
Lesinurad does not accumulate following multiple doses.
Co-administration of pitolisant with rifampicin in multiple doses significantly decreases pitolisant mean Cmax and AUC ratio about 39% and 50%.
Digoxin(0.5 mg single dose)/Cobicistat 150 mg multiple doses.
The steady-state mean Cmax, AUCtau, and Ctrough(mean± SD) following multiple doses of Stribild in HIV-1 infected subjects, respectively, were 1.7± 0.39 µg/mL.
In accordance with the half-life, the accumulation index is 5 to 6 based on AUC0-24h following multiple doses of 5 to 20 mg/day.
Multiple doses of mirabegron up to 300 mg daily for 10 days showed increases in pulse rate and systolic blood pressure when administered to healthy volunteers.
The maximum amount of Aranesp that can be safely administered in single or multiple doses has not been determined.
However, multiple doses of ambrisentan had no clinically relevant effect on cyclosporine A exposure, and no dose adjustment of cyclosporine A is warranted.
Canagliflozin does not exhibit time-dependent pharmacokinetics, andaccumulated in plasma up to 36% following multiple doses of 100 mg and 300 mg.
The mean total body systemic clearance of pegvisomant following multiple doses is estimated to be 28 ml/h for subcutaneous doses ranging from 10 to 20 mg/day.
There is little or no accumulation of topotecan with repeated daily dosing andthere is no evidence of a change in the PK after multiple doses.
Irrespective of the dose and whether lixisenatide was administered as single or multiple doses, the median tmax is 1 to 3.5 hours in patients with type 2 diabetes.
Plasma levels of Canrenone powder and‘total metabolites' after base hydrolysis were compared in young andelderly subjects following single and multiple doses of spironolactone.
In clinical trials of other quinolones using multiple doses patients were marked ophthalmic disorders, including cataracts, Multiple point clouding of the lens.
The mean terminal elimination half-life of stavudine is 1.3 to 2.3 hours following single or multiple doses, and is independent of dose. .
Co- administration of multiple doses of linagliptin and metformin did not meaningfully alter the pharmacokinetics of either linagliptin or metformin in healthy volunteers and patients.
The overall exposure of adolescents(12 to≤17 years) and children(2 to< 12 years)to deferasirox after single and multiple doses was lower than that in adult patients.
Multiple doses of 90 mg per day for 12 days in a patient resulted in pneumonia, systemic inflammatory response, atrial fibrillation, and asymptomatic, moderate pericardial effusion.
No clinically relevant effect was observed during steady-state lithium exposure following co- administration with multiple doses of vortioxetine in healthy subjects.
It was demonstrated in a clinical study with intravenous midazolam that multiple doses of telavancin had no effect on the pharmacokinetics of midazolam, which is a sensitive substrate for CYP3A4.